In recent trading, Humana Inc. (Symbol: HUM) has seen its shares rise above the average analyst 12-month target price of $302.14, now trading at $304.18 per share. When a stock reaches an analyst’s target, they typically face two choices: either downgrade their valuation or adjust their target price higher. The decision may also depend on recent business developments that have contributed to the stock’s upward movement. If positive trends continue, they might opt to raise their price target.
Within the Zacks coverage universe, there are 22 different analyst targets for Humana Inc. This average target represents a mix of opinions. Among them, one analyst has set a lower target at $248.00, while another’s target is as high as $550.00. The standard deviation stands at $67.178, indicating a significant range of expectations.
The reason for reviewing the average target price for HUM is to gather insights from multiple analysts rather than relying on a single viewpoint. With HUM now trading above the average target price of $302.14, investors may want to reassess the company’s prospects. Is $302.14 merely a stepping stone toward higher targets, or is the price high enough to consider selling some shares? Below is a summary of the latest analyst opinions on Humana Inc.
| Recent HUM Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong buy ratings: | 6 | 6 | 10 | 10 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 17 | 16 | 12 | 12 |
| Sell ratings: | 0 | 1 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 2.46 | 2.5 | 2.09 | 2.09 |
The average rating is based on a scale from 1 to 5, where 1 means Strong Buy and 5 means Strong Sell. This article utilized data provided by Zacks Investment Research via Quandl.com. For the latest Zacks research report on HUM, feel free to explore.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• LFCR shares outstanding history
• SHEL Videos
• Funds Holding SONO
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
